113082-99-8 Usage
Description
(5E)-Calcipotriene, also known as the trans-isomeric impurity of Calcipotriene, is a vitamin D3 analogue with antitumor effects. It is a white to off-white solid and has potential applications in various industries due to its unique chemical properties and biological activities.
Uses
Used in Pharmaceutical Industry:
(5E)-Calcipotriene is used as an active pharmaceutical ingredient for its antitumor effects. It has the potential to be developed into a drug for the treatment of various types of cancer.
Used in Cosmetic Industry:
(5E)-Calcipotriene can be used as an ingredient in cosmetic products for its potential skin health benefits. Its vitamin D3 analogue properties may contribute to improved skin hydration, elasticity, and overall skin health.
Used in Research and Development:
(5E)-Calcipotriene can be utilized in research and development for the discovery of new drugs and therapies. Its unique chemical properties and biological activities make it a valuable compound for studying the mechanisms of action and potential applications in various diseases and conditions.
Used in Drug Delivery Systems:
(5E)-Calcipotriene can be incorporated into drug delivery systems to improve the efficacy and targeted delivery of therapeutic agents. Its chemical properties may allow for the development of novel drug delivery platforms, enhancing the bioavailability and therapeutic outcomes of various treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 113082-99-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,0,8 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 113082-99:
(8*1)+(7*1)+(6*3)+(5*0)+(4*8)+(3*2)+(2*9)+(1*9)=98
98 % 10 = 8
So 113082-99-8 is a valid CAS Registry Number.
113082-99-8Relevant articles and documents
Method for preparing analogue of vitamin D
-
Page/Page column 10, (2008/06/13)
A method for preparing analogues of C1,C24-dihydroxy-vitamin D is disclosed. Especially the method for preparing calcipotriol and tacalcitol from a starting material of Vitamin D2 is disclosed here. Calcipotriol (compound 1(a)) and tacalcitol (compound 1(b)) can be synthesized by the method of the present invention. Moreover, only nine steps are needed for the synthesis of calcipotriol using the method. Likewise, only ten steps are needed for the synthesis of tacalcitol by the present method. Hence, the present method, with less process steps and higher yields, represents an improvement over the conventional methods.